Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...
This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...
A team of industry leaders and the University of North Dakota are targeting the nation’s $966 billion chronic disease ...
Thanks to the oral surgeon who extracted four wisdom teeth from my college student's mouth and the ...
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...
The US Food and Drug Administration (FDA) issued a complete response letter (CRL) regarding the Biologics License Application ...
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for LusvertikimabDevelopment built on strong ...
CalMatters reports that dancers believe AI can't replicate their craft's emotional and cultural depth, despite recent ...
February 2026 Imfinzi perioperative regimen recommended for approval in the EU by CHMP for patients with early gastric and gastroesophageal cancers Recommendation based on MATTERHORN Phase III trial ...
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...
New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results